QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
LON:ABC

Abcam - ABC Share Forecast, Price & News

GBX 1,275.96
-51.04 (-3.85%)
(As of 12/6/2022 05:24 PM ET)
Add
Compare
Today's Range
1,261
▼
1,375
50-Day Range
1,247
▼
1,454
52-Week Range
1,013.57
▼
1,760
Volume
261,108 shs
Average Volume
365,095 shs
Market Capitalization
£2.93 billion
P/E Ratio
18,227.96
Dividend Yield
0.91%
Price Target
GBX 1,462.50

Abcam MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
14.6% Upside
GBX 1,462.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.13mentions of Abcam in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
£25.64 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.12 out of 5 stars

See Top Rated MarketRank™ Stocks Here
ABC stock logo

About Abcam (LON:ABC) Stock

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

ABC Stock News Headlines

December 6, 2022 | marketwatch.com
Catharanthine Market Size, Trends and Forecast 2028 with Top Countries Data
December 3, 2022 | marketwatch.com
Myoglobin ELISA Test Kit Market Size, Recent Trends, Demand and Share Estimation By 2028 with Fastest Growing Countries Data | 87 Pages Report
December 3, 2022 | americanbankingnews.com
Michael Baldock Sells 18,032 Shares of Abcam plc (LON:ABC) Stock
December 2, 2022 | marketwatch.com
NBQX Disodium Salt Market Covering the full spectrum of global [Categeory] to 2028 | Newst 102 Pages Report
November 30, 2022 | marketwatch.com
Erythropoietin ELISA Test Kit Market 2022 : Technology Type Analysis, Size, Share, Growth, Price Trends and Forecast To 2028 | 87 Pages Report
November 30, 2022 | marketwatch.com
Alkaline Phosphatase Assay Kits Market Size In 2022 : Future Scope, Demands and Projected Technology Type Growths to 2028 | 117 Pages Report
November 29, 2022 | msn.com
Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday
November 28, 2022 | marketwatch.com
Thromboxane A2 (TXA2) ELISA Kit Market : An complete research On Upcoming Trends And Growth Opportunities from 2023-2028
November 27, 2022 | americanbankingnews.com
Abcam (LON:ABC) Stock Passes Above Two Hundred Day Moving Average of $1,251.56
November 25, 2022 | marketwatch.com
384-Well Microplates Market Size And Opportunities for New Players, Forecast from 2023 To 2028 with Top Countries Data
November 25, 2022 | marketwatch.com
Apocynin Market : Key Player, Competition Weakness and Strengths from 2023 to 2028
November 23, 2022 | marketwatch.com
Oxidative Stress Assay for Pharmaceutical Market 2022 Industry Scenario, Strategies, Growth Factors and Forecast to 2028
November 23, 2022 | finance.yahoo.com
Neuroscience Antibodies and Assays Market 2023-2027: 5-Year (2017-2021) Historic Industry Size & Analysis of 15 Vendors and 7 Countries
November 22, 2022 | marketwatch.com
Oxidative Stress Assay Market 2023 Report Offers Key Futuristic Top Trends And Competitive Landscape By 2028
November 18, 2022 | marketwatch.com
Arecoline Hydrobromide Market : Competitive Strategy Analysis and Forecast Values 2022-2028
November 18, 2022 | marketwatch.com
Puerarin Market Size in 2023 ( New Report ) by Region, End User Overview with the Best Scope to New Players-Global Business Forecast till 2028
November 18, 2022 | marketwatch.com
Global Aerrane Market Size 2022 Research Analysis by Production Sites, Area Served, Product Types and Forecast to 2028
November 18, 2022 | marketwatch.com
In Situ Hybridization Market worth $2.8 billion by 2027 – Exclusive Report by MarketsandMarkets(TM)
November 17, 2022 | marketwatch.com
Global Clinical Grade Antibody Portfolio Market Size 2022 Research Analysis by Production Sites, Area Served, Product Types and Forecast to 2028
November 16, 2022 | finance.yahoo.com
Is Abcam the Perfect Nasdaq Stock?
November 16, 2022 | marketwatch.com
Global RANTES ELISA Kit Market Size 2022 Research Analysis by Production Sites, Area Served, Product Types and Forecast to 2028
November 15, 2022 | marketwatch.com
Recombinant Antibody Market 2023: Global Research by Size, Share, Growth Trends, Manufacturers, and Regional Demand Scope Forecast to 2029
November 15, 2022 | marketwatch.com
Global Immunoprecipitation Market Size 2022 Research Report by Manufactures, Market Breakdown, Data Triangulation, Trends and Forecast to 2028
November 15, 2022 | benzinga.com
Antibody Production Market is expected to generate a revenue of USD 9.28 Billion by 2030, Globally, at 13.14% CAGR: Verified Market Research®
November 11, 2022 | marketwatch.com
BCL-2 (B-cell lymphoma 2) Inhibitors Market Trends 2023 Growth Factor, Industry Challenge, Share, Business Overview, Size and Forecast to 2028
See More Headlines
Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:ABC
CUSIP
N/A
CIK
N/A
Web
www.abcam.com
Phone
+44-1223-696000
Fax
N/A
Employees
1,650
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,462.50
High Stock Price Forecast
GBX 1,700
Low Stock Price Forecast
GBX 1,250
Forecasted Upside/Downside
+14.6%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
18,227.96
Forward P/E Ratio
33.15
P/E Growth
1.72
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
31.60
Current Ratio
1.27
Quick Ratio
0.89

Sales & Book Value

Annual Sales
£350.40 million
Price / Sales
8.35
Cash Flow
GBX 44.94 per share
Price / Cash Flow
28.39
Book Value
GBX 318.30 per share
Price / Book
4.01

Miscellaneous

Outstanding Shares
229,272,000
Free Float
N/A
Market Cap
£2.93 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 54)
    M.B.A., M.S., MBA, MS, CEO & Exec. Director
    Comp: $1.23M
  • Mr. Michael Shaun Baldock B.A. (Age 58)
    CFO & Director
    Comp: $881.14k
  • Mr. Mark Dermody
    Interim CIO
  • James Staveley
    VP of Investor Relations
  • Marc Perkins
    Gen. Counsel & Company Sec.
  • Emma Sceats
    Sr. VP of Sales, Service & Bus. Devel.
  • Mr. Nick Skinner
    Sr. VP of HR
  • Mr. Mark Bushfield
    Sr. VP of Research & Innovation
  • Ms. Kirstie Speck BBusSc
    Head of Consumer Insights
  • Ms. Yvonne Chien
    Sr. VP of Customer Experience

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ABC Stock - Frequently Asked Questions

Should I buy or sell Abcam stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ABC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABC, but not buy additional shares or sell existing shares.
View ABC analyst ratings or view top-rated stocks.

What is Abcam's stock price forecast for 2023?

4 brokerages have issued 12-month price targets for Abcam's stock. Their ABC share price forecasts range from GBX 1,250 to GBX 1,700. On average, they expect the company's stock price to reach GBX 1,462.50 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price.
View analysts price targets for ABC or view top-rated stocks among Wall Street analysts.

How have ABC shares performed in 2022?

Abcam's stock was trading at GBX 1,733 at the beginning of the year. Since then, ABC stock has decreased by 26.9% and is now trading at GBX 1,267.
View the best growth stocks for 2022 here.

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA).

What is Abcam's stock symbol?

Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC."

How do I buy shares of Abcam?

Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Abcam's stock price today?

One share of ABC stock can currently be purchased for approximately GBX 1,267.

How much money does Abcam make?

Abcam (LON:ABC) has a market capitalization of £2.90 billion and generates £350.40 million in revenue each year.

How many employees does Abcam have?

The company employs 1,650 workers across the globe.

How can I contact Abcam?

Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The official website for the company is www.abcam.com. The company can be reached via phone at +44-1223-696000.

This page (LON:ABC) was last updated on 12/6/2022 by MarketBeat.com Staff